Medical Affairs 2.0: GenAI as the Catalyst for Change in Writing, MedComms, and Field Strategy
Digital and AI were hot topics underpinning many of the conversations at the DIA’s Medical Affairs and Scientific Communications (DIA MASC) forum I attended in March 2025, along with a focus on how we can utilize these tools to achieve impactful, engaging, and scientifically accurate communications that resonate with healthcare providers (HCPs) and patients. Along…...
Read MoreTop Stories
Biopharma Trends 2025: 3 Things to Know Right Now
The global business climate is ever-evolving, and 2025 looks...
Science, AI, and Human Ingenuity Converge to
Today, we're witnessing an unprecedented convergence of...
The Paradigm Shift from Traditional Scientific
In the rapidly evolving biopharma landscape, the approach to...
Filter
Didactic to Dynamic: Innovative Approaches to Deeper Payer Engagements
HEOR is a fast-evolving field. Feedback from payers can influence research plans and help create...
HEOR in 2022: The Importance of Data Visualization, RWD, and Interactive Formats
Effectively communicating data in the pharmaceutical and medical community is vital to payer engagement. Learn...
Pharma, Physician, and Patient Pain Points Regarding Clinical Trials
Pharma, physicians, and patients consistently face challenges related to clinical trials. Here's a quick look...
Clinical Trial Summaries – What Are They and Why Do They Matter for Pharma?
A majority of patients feel lay summaries for clinical trials are very important and won’t...
3 Factors That Will Help Pharma Build Public Trust
Pharma must engage with patients at all levels to build public trust...